Takeda Pharmaceutical Company Limited (TAK) Earnings Dates & History
NYSE·Healthcare·Drug Manufacturers - Specialty & Generic
$20.28
-0.73%
Mkt Cap $57.09B
EPS — Estimate vs Actual
Quarterly History
Quarters are fiscal periods. Fiscal year ends in October.
| Q3 2025 May 13, 2026 | $7.17B | $6.94B | -3.15% | -$0.08 | -$0.05 | +34.58% |
| Q1 2026 Jan 29, 2026 | $7.54B | $7.73B | +2.48% | $0.55 | $0.48 | -12.73% |
| Q4 2025 Oct 30, 2025 | $7.48B | $7.42B | -0.85% | $0.44 | $0.44 | +0.00% |
| Q3 2025 Jul 30, 2025 | $7.95B | $7.64B | -3.91% | $0.47 | $0.52 | +10.64% |
| Q2 2025 Jun 25, 2025 | — | $7.24B | — | — | -$0.22 | — |
| Q1 2025 Jan 30, 2025 | $7.06B | $7.28B | +3.02% | $0.63 | $0.42 | -33.33% |
| Q4 2024 Oct 31, 2024 | $7.45B | $7.91B | +6.12% | $0.39 | $0.44 | +12.82% |
| Q3 2024 Jul 31, 2024 | $6.98B | $7.52B | +7.69% | $0.37 | $0.56 | +51.35% |
| Q2 2024 May 9, 2024 | $6.06B | $6.93B | +14.28% | $0.00 | -$0.01 | -330.55% |
| Q1 2024 Feb 1, 2024 | $6.76B | $7.94B | +17.46% | $0.10 | $0.51 | +420.51% |
| Q4 2023 Oct 26, 2023 | $6.75B | $6.98B | +3.36% | $0.10 | $0.50 | +418.13% |
| Q3 2023 Jul 27, 2023 | $7.12B | $7.33B | +2.94% | $0.14 | $0.55 | +287.87% |
| Q2 2023 May 11, 2023 | $7.16B | $7.22B | +0.82% | $0.05 | $0.39 | +672.43% |
| Q1 2023 Feb 2, 2023 | $7.45B | $8.45B | +13.51% | $0.28 | $0.46 | +62.09% |
| Q2 2022 May 11, 2022 | $6.94B | $7.14B | +2.95% | $0.06 | $0.38 | +527.06% |
| Q1 2022 Feb 3, 2022 | $7.28B | $7.84B | +7.70% | $0.22 | $0.54 | +144.90% |
| Q2 2021 May 11, 2021 | — | $6.97B | — | — | $0.41 | — |
| Q4 2020 Oct 29, 2020 | $1.41T | $7.47B | -99.47% | $103.00 | $0.47 | -99.54% |
| Q3 2020 Jul 31, 2020 | $3.15T | $7.45B | -99.76% | $104.00 | $0.57 | -99.45% |
| Q2 2020 May 13, 2020 | — | $7.14B | — | — | $0.13 | — |
| Q1 2020 Feb 4, 2020 | $1.52T | $7.93B | -99.48% | $75.00 | $0.53 | -99.29% |
| Q4 2019 Oct 31, 2019 | — | $7.57B | — | — | $0.59 | — |
| Q3 2019 Jul 31, 2019 | — | $7.88B | — | — | $0.56 | — |
| Q2 2019 May 14, 2019 | — | $6.47B | — | — | $0.13 | — |
| Q1 2019 Feb 1, 2019 | — | $4.45B | — | — | $0.75 | — |
| Q4 2018 Oct 31, 2018 | — | $3.80B | — | — | $0.27 | — |
| Q3 2018 Jul 31, 2018 | — | $4.07B | — | — | $0.45 | — |
| Q2 2018 May 14, 2018 | — | $3.77B | — | — | -$0.33 | — |
| Q4 2017 Dec 31, 2017 | — | $4.30B | — | — | $0.38 | — |
| Q3 2017 Sep 30, 2017 | — | $3.85B | — | — | $0.16 | — |
| Q2 2017 Jun 30, 2017 | — | $3.99B | — | — | $0.82 | — |
| Q1 2017 Mar 31, 2017 | — | $3.74B | — | — | -$0.29 | — |
| Q4 2016 Dec 31, 2016 | — | $3.98B | — | — | $0.23 | — |
| Q3 2016 Sep 30, 2016 | — | $4.12B | — | — | $0.16 | — |
| Q2 2016 Jun 30, 2016 | — | $4.22B | — | — | $0.31 | — |
| Q1 2016 Mar 31, 2016 | — | $3.69B | — | — | -$0.10 | — |
| Q4 2015 Dec 31, 2015 | — | $4.06B | — | — | $0.16 | — |
| Q3 2015 Sep 30, 2015 | — | $3.81B | — | — | $0.08 | — |
| Q2 2015 Jun 30, 2015 | — | $3.63B | — | — | $0.06 | — |
| Q1 2015 Mar 31, 2015 | — | $3.66B | — | — | -$0.60 | — |
| Q4 2014 Dec 31, 2014 | — | $4.41B | — | — | $0.05 | — |
| Q3 2014 Sep 30, 2014 | — | $4.04B | — | — | $0.08 | — |
| Q2 2014 Jun 30, 2014 | — | $4.03B | — | — | $0.10 | — |
| Q1 2014 Mar 31, 2014 | — | $3.90B | — | — | -$0.01 | — |
| Q4 2013 Dec 31, 2013 | — | $4.98B | — | — | $0.19 | — |
| Q3 2013 Sep 30, 2013 | — | $4.29B | — | — | $0.14 | — |
| Q2 2013 Jun 30, 2013 | — | $4.15B | — | — | $0.09 | — |
| Q1 2013 Mar 31, 2013 | — | $3.91B | — | — | -$0.03 | — |
| Q4 2012 Dec 31, 2012 | — | $5.13B | — | — | $0.08 | — |
| Q3 2012 Sep 30, 2012 | — | $4.99B | — | — | $0.13 | — |
| Q2 2012 Jun 30, 2012 | — | $5.00B | — | — | $0.35 | — |
| Q1 2012 Mar 31, 2012 | — | $4.60B | — | — | -$0.14 | — |
| Q4 2011 Dec 31, 2011 | — | $5.41B | — | — | $0.10 | — |
| Q3 2011 Sep 30, 2011 | — | $4.48B | — | — | $0.25 | — |
| Q2 2011 Jun 30, 2011 | — | $4.41B | — | — | $0.30 | — |
| Q1 2011 Mar 31, 2011 | — | $4.04B | — | — | $0.12 | — |
| Q4 2010 Dec 31, 2010 | — | $4.48B | — | — | $0.28 | — |
| Q3 2010 Sep 30, 2010 | — | $4.29B | — | — | $0.30 | — |
| Q2 2010 Jun 30, 2010 | — | $4.02B | — | — | $0.23 | — |
| Q1 2010 Mar 31, 2010 | — | $3.58B | — | — | $0.13 | — |
| Q4 2009 Dec 31, 2009 | — | $4.00B | — | — | $0.24 | — |
| Q3 2009 Sep 30, 2009 | — | $4.18B | — | — | $0.27 | — |
| Q2 2009 Jun 30, 2009 | — | $3.93B | — | — | $0.37 | — |
| Q1 2009 Mar 31, 2009 | — | $3.35B | — | — | $0.21 | — |
| Q4 2008 Dec 31, 2008 | — | $3.89B | — | — | $0.30 | — |
| Q3 2008 Sep 30, 2008 | — | $3.90B | — | — | $0.21 | — |